TABLE 3.
H.C (n = 8) | Ca.C (n = 8) | Ca.VD (n = 8) | Ca.Ex (n = 7) | Ca.Ex.VD (n = 6) | ||
Weight (g) | F.W | 31.25 ± 1.58 | 29.13 ± 2.64 | 30.88 ± 1.36 | 31.00 ± 2.00 | 30.67 ± 3.08 |
L.W | 35.75 ± 2.12 | 28.38 ± 7.93* | 31.63 ± 1.60* | 31.29 ± 1.98* | 31.87 ± 2.40* | |
Volume of tumor (mm3) | F.W | † | 0.044 ± 0.005 | 0.051 ± 0.002 | 0.046 ± 0.005 | 0.047 ± 0.007 |
L.W | † | 0.279 ± 0.037 | 0.399 ± 0.030 | 0.313 ± 0.046 | 0.263 ± 0.019 | |
L.W/LW | † | 6.34 ± 0.02 | 7.82 ± 0.02 | 6.80 ± 0.03 | 5.60 ± 0.01 * | |
% T.V.D | † | 0% | + 23% | + 7% | 12% |
*P ≤ 0.05, F.W, first week; L.W, last week; L.W/LW, the ratio of the tumor volume from the last week to the first week. † = no tumor; % T.V.D, percentage of tumor volume development; H.C, healthy control group; Ca.C, cancer control group; Ca.VD, cancer with injection of vitamin D group; Ca.Ex, cancer exercise training group; Ca.Ex.VD, cancer exercise training with injection of vitamin D group.